total daily dose of insulin and ratio of doses of basal/prandial insulines

patients´satisfaction

Estimated Enrollment:

35

Study Start Date:

April 2006

Estimated Study Completion Date:

November 2006

Eligibility

Ages Eligible for Study:

18 Years to 65 Years

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Patients with Diabetes Mellitus Type 1 and Diabetes Mellitus Type 2 with HbA1c 6% and more with more than 2 confirmed hypoglycaemic events (glycaemia less than 3,3 mmol/l) during last year

Exclusion Criteria:

Diabetic ketoacidosis

Any other severe disease

Pregnancy or fertile female without contraception

Alcohol/drug abuse, selected prohibited concomitant medication

Nightshift work

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00322075